Jyothy Labs Limited (IN:JYOTHYLAB)
:JYOTHYLAB
Want to see IN:JYOTHYLAB full AI Analyst Report?
Top Page
Jyothy Labs Limited
(JYOTHYLAB)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹287.00
▲(3.84% Upside)
Action:ReiteratedDate:03/17/26
The score is driven primarily by strong financial performance (growth, margins, and a very low-debt balance sheet). This is meaningfully offset by weak technical conditions (below key moving averages with negative MACD) and a relatively high P/E, with the dividend yield providing only limited valuation support.
Positive Factors
Revenue & Margin Trend
Sustained top-line growth coupled with improving gross margins signals durable demand and better cost control. This combination supports scalable operating leverage, strengthens pricing power versus input-cost volatility, and underpins long-term cash generation for brand investment.
Negative Factors
Recent OCF Decline
A drop in operating cash flow signals potential working-capital pressure or timing issues in receivables/inventory that can reduce free cash availability. If persistent, this could constrain marketing spends or capital allocation and weaken resilience to input-cost shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & Margin Trend
Sustained top-line growth coupled with improving gross margins signals durable demand and better cost control. This combination supports scalable operating leverage, strengthens pricing power versus input-cost volatility, and underpins long-term cash generation for brand investment.
Read all positive factors
Jyothy Labs Limited (JYOTHYLAB) vs. iShares MSCI India ETF (INDA)
Market Cap
₹98.65B
Dividend Yield1.24%
Average Volume (3M)26.54K
Price to Earnings (P/E)32.0
Beta (1Y)0.90
Revenue Growth1.90%
EPS Growth-8.15%
CountryIN
Employees2,943
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)2.20
Shares Outstanding367,214,500
10 Day Avg. Volume19,687
30 Day Avg. Volume26,541
Financial Highlights & Ratios
PEG Ratio109.35
Price to Book (P/B)5.89
Price to Sales (P/S)4.21
P/FCF Ratio47.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹270.00Price Target Upside-2.32% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)10.74
Revenue Forecast (FY)₹31.91B
Jyothy Labs Limited Business Overview & Revenue Model
Company Description
Jyothy Labs Limited, together with its subsidiaries, engages in manufacturing and marketing fabric care, dishwashing, personal care, and household insecticides products in India and internationally. The company operates through Dishwashing, Fabric...
How the Company Makes Money
Jyothy Labs primarily makes money by manufacturing (in-house and/or through third-party manufacturing) and selling branded FMCG products to distributors/wholesalers and retail channels, with revenue recognized from product sales across its key cat...
Jyothy Labs Limited Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
78
Positive
Cash Flow
76
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.80B | 28.68B | 27.61B | 24.86B | 21.97B | 19.10B |
| Gross Profit | 14.04B | 14.39B | 13.48B | 10.42B | 9.06B | 8.92B |
| EBITDA | 4.97B | 5.05B | 4.74B | 3.08B | 2.39B | 3.09B |
| Net Income | 3.48B | 3.70B | 3.69B | 2.40B | 1.62B | 1.99B |
Balance Sheet | ||||||
| Total Assets | 21.22B | 26.91B | 24.01B | 20.62B | 20.23B | 19.56B |
| Cash, Cash Equivalents and Short-Term Investments | 8.05B | 5.99B | 6.16B | 2.81B | 2.09B | 1.94B |
| Total Debt | 537.40M | 612.80M | 505.60M | 465.30M | 1.71B | 1.67B |
| Total Liabilities | 6.84B | 6.41B | 5.91B | 5.11B | 6.20B | 5.65B |
| Stockholders Equity | 14.38B | 20.50B | 18.08B | 15.49B | 14.44B | 14.29B |
Cash Flow | ||||||
| Free Cash Flow | 1.61B | 2.53B | 4.21B | 2.93B | 1.77B | 3.76B |
| Operating Cash Flow | 1.96B | 3.11B | 4.58B | 3.29B | 2.03B | 4.02B |
| Investing Cash Flow | -1.17B | -1.61B | -3.44B | -482.90M | -317.13M | -1.29B |
| Financing Cash Flow | -1.44B | -1.57B | -1.35B | -2.51B | -1.67B | -2.16B |
Jyothy Labs Limited Technical Analysis
Neutral
276.40
Price Trends
232.14
Positive
255.22
Negative
291.11
Negative
Market Momentum
-0.66
Negative
60.52
Neutral
92.37
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JYOTHYLAB, the sentiment is Neutral. The current price of 276.4 is above the 20-day moving average (MA) of 214.37, above the 50-day MA of 232.14, and below the 200-day MA of 291.11, indicating a neutral trend. The MACD of -0.66 indicates Negative momentum. The RSI at 60.52 is Neutral, neither overbought nor oversold. The STOCH value of 92.37 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:JYOTHYLAB.
Jyothy Labs Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹1.02T | 54.57 | ― | 1.42% | 25.33% | 6.63% | |
67 Neutral | ₹5.47T | 20.59 | ― | 1.84% | 3.52% | 35.08% | |
66 Neutral | ₹802.33B | 39.88 | ― | 1.62% | 3.48% | 2.69% | |
65 Neutral | ₹334.96B | 38.08 | ― | 2.08% | -0.44% | 1.84% | |
64 Neutral | ₹98.65B | 31.99 | ― | 1.24% | 1.90% | -8.15% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ₹1.11T | 62.79 | ― | 1.67% | 7.29% | ― |
* Consumer Defensive Sector Average
IN:JYOTHYLAB
Jyothy Labs Limited
262.65
-111.28
-29.76%
IN:DABUR
Dabur India Limited
449.85
-26.53
-5.57%
IN:GODREJCP
Godrej Consumer Products Limited
1,092.35
-149.00
-12.00%
IN:HINDUNILVR
Hindustan Unilever Limited
2,288.25
43.14
1.92%
IN:MARICO
Marico Limited
781.10
76.57
10.87%
IN:PGHH
Procter & Gamble Hygiene & Health Care Ltd.
10,176.40
-3,855.87
-27.48%
Jyothy Labs Limited Corporate Events
Jyothy Labs Shuts Trading Window Ahead of FY26 Results
Mar 26, 2026
Jyothy Labs Limited has announced the closure of its trading window for designated persons and their immediate relatives starting April 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and its internal code of conduct....
Jyothy Labs Plans Routine One-on-One Meeting With Mirabilis Investment Trust
Mar 10, 2026
Jyothy Labs Limited has scheduled an investor and analyst meeting with Mirabilis Investment Trust on March 12, 2026, to be held as a one-on-one interaction. The company has clarified that no unpublished price-sensitive information will be shared d...
Jyothy Labs Schedules Investor Meeting With Eternity Capital
Mar 10, 2026
Jyothy Labs Limited has notified stock exchanges about a scheduled investor and analyst meeting with Eternity Capital on March 11, 2026. The company clarified that the interaction will not involve sharing any unpublished price-sensitive informatio...
Jyothy Labs Shares Q3 and Nine-Month FY25 Performance in Investor Presentation
Feb 9, 2026
Jyothy Labs Limited has submitted to the BSE and the National Stock Exchange a copy of its investor presentation detailing the company’s performance for the quarter and nine months ended December 31, 2025. The presentation, which is also ava...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.